M&A Deal Summary

IBM Acquires Octo

On December 7, 2022, IBM acquired information technology company Octo from Arlington Capital Partners

Acquisition Highlights
  • This is IBM’s 40th transaction in the Information Technology sector.
  • This is IBM’s 135th transaction in the United States.
  • This is IBM’s 4th transaction in Virginia.

M&A Deal Summary

Date 2022-12-07
Target Octo
Sector Information Technology
Buyer(s) IBM
Sellers(s) Arlington Capital Partners
Deal Type Add-on Acquisition

Target

Octo

Reston, Virginia, United States
Octo is a provider of digital services for the Federal Government. Octo specializes in providing agile software development, user experience design, and cloud engineering services that address the government’s most pressing missions and modernization challenges. Octo is based in Reston, Virginia.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

IBM

Armonk, New York, United States

Category Company
Founded 1911
Sector Information Technology
Employees282,200
Revenue 61.9B USD (2023)
DESCRIPTION
Entrance to IBM's corporate headquarters in Armonk, New York.
Entrance to IBM's corporate headquarters in Armonk, New York.

IBM is a global provider of information technology products and services. IBM's products and services include IT infrastructure and business process services, cloud computing, business analytics, and enterprise software. IBM was formed in 1911 and is based in Armonk, New York.


DEAL STATS #
Overall 190 of 198
Sector (Information Technology) 40 of 44
Type (Add-on Acquisition) 169 of 175
State (Virginia) 4 of 5
Country (United States) 135 of 142
Year (2022) 7 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-22 Dialexa

Dallas, Texas, United States

Dialexa is a U.S. digital product engineering services firm, to help companies drive innovation and achieve their digital growth agendas. Dialexa was founded in 2010 and is based in Dallas, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-28 NS1

New York, New York, United States

NS1 is a provider of network automation SaaS solutions that are designed to enable businesses to deliver content, services and applications to millions of users while helping optimize performance, reliability, security and cost. NS1 was formed in 2013 and is based in New York City.

Buy -

Seller(S) 1

SELLER

Arlington Capital Partners

Chevy Chase, Maryland, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1999
PE ASSETS 7.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Arlington Capital Partners is a middle-market private equity firm focused on buyouts and recapitalizations in targeted growth industries. Arlington targets US based companies valued between $50 and $500 million with strong potential for organic growth and possible consolidation opportunities. Sectors of interest include business services and outsourcing, aerospace/defense, federal and commercial IT, media, education and training, healthcare services, and manufacturing. Arlington Capital was formed in 1999 and is headquartered in Washington DC.


DEAL STATS #
Overall 34 of 38
Sector (Information Technology) 11 of 12
Type (Add-on Acquisition) 17 of 20
State (Virginia) 10 of 11
Country (United States) 32 of 36
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-11 Millstone Medical Outsourcing

Fall River, Massachusetts, United States

Millstone Medical Outsourcing is a provider of outsourcing solutions to medical device OEMs, including contract packaging services alongside innovative warehousing and distribution services. Millstone Medical Outsourcing was founded in 2000 and is based in Fall River, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-05 AVS Bio

Norwich, Connecticut, United States

AVS Bio is a provider of specific pathogen free eggs and adjacent laboratory products and services that support the development and manufacture of vaccines, therapeutics, and other biologics used for human and animal health. AVS Bio was founded in 1961 and is based in Norwich, Connecticut.

Buy -